MEDICAL BOARD OF CALIFORNIA
Executive Director, Kimberly Kirchmeyer: (916) 263-2389 ♦ License Verification,
General Licensing, Application and Complaint Information (Toll-Free): 1-800-633-2322
♦ Office of Public Affairs: (916) 262-2394 ♦ Website: www.mbc.ca.gov
Protection of the public shall be the highest priority for the Medical Board
of California in exercising its licensing, regulatory, and disciplinary
functions. Whenever the protection of the public is inconsistent with other
interests sought to be promoted, the protection of the public shall be
paramount.

T

—Business and Professions Code § 2000.1
he Medical Board of California (MBC) is a consumer protection
agency within the state Department of Consumer Affairs (DCA). The
15-member Board consists of eight physicians and seven public

members. MBC members are appointed by the Governor (who appoints all eight physicians
and five public members), the Speaker of the Assembly (one public member), and the
Senate Rules Committee (one public member). Members serve a four-year term and may
be reappointed to a second term. The Board is assisted by several standing committees and
ad hoc task forces.
The purposes of MBC are to protect consumers from incompetent, grossly
negligent, unlicensed, impaired, or unethical practitioners; enforce the provisions of the
Medical Practice Act, Business and Professions Code section 2000 et seq.; provide publicrecord information about physicians to the public via its website and individual requests;
and educate healing arts licensees and the public on health quality issues. The Board’s
regulations are codified in Division 13, Title 16 of the California Code of Regulations
(CCR).
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MBC is responsible for ensuring that all physicians licensed in California have
adequate medical education and training. In this regard, the Board issues regular and
probationary licenses and certificates under its jurisdiction, administers a continuing
medical education program, and administers physician and surgeon examinations to some
license applicants. MBC also oversees the regulation of licensed midwives;
polysomnographic technologists, technicians, and trainees; research psychoanalysts; and
medical assistants.
In response to complaints from the public and reports from health care facilities and
other mandated reporters, MBC reviews the quality of medical practice carried out by
physicians and surgeons. In this regard, MBC’s responsibilities include enforcement of the
disciplinary, administrative, criminal, and civil provisions of the Medical Practice Act.
MBC’s enforcement staff receives and evaluates complaints and reports of misconduct and
negligence against physicians. If there is reason to suspect a violation of the Medical
Practice Act, an investigator from DCA’s Health Quality Investigation Unit (HQIU),
together with a deputy attorney general (DAG) from the Health Quality Enforcement
Section (HQE) in the Attorney General’s Office, will investigate the allegations and may
file charges against alleged violators. Barring a stipulated settlement, the HQE DAG will
prosecute the charges at an evidentiary hearing before an administrative law judge (ALJ)
from the special Medical Quality Hearing Panel within the Office of Administrative
Hearings (OAH). Following the hearing, a seven-member panel of MBC reviews the ALJ’s
proposed decision and takes final disciplinary action to revoke, suspend, or restrict the
license, or impose other appropriate administrative action.
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MBC meets approximately four times per year; its committees and task forces hold
additional separate meetings as the need arises.
At this writing, the Board has three vacancies—one physician member and two
public members—all of which must be filled by Governor-elect Gavin Newsom.

MAJOR PROJECTS
Legislative Oversight Hearing Regarding Patient
Protection
On June 18, 2018, the Senate Committee on Business, Professions and Economic
Development Committee convened an oversight hearing, entitled “Sexual Misconduct
Reporting in the Medical Profession: Missed Opportunities to Protect Patients,” to examine
health practitioner discipline, and to provide Committee members information about
current reporting requirements and potential loopholes in the law. The hearing was a
response to the public outcry after news reports that hundreds of women had complained
to the University of Southern California (USC) about its student health center’s
gynecologist, George Tyndall, and his pattern of sexual misconduct for decades. New
reports revealed that university officials did not report Dr. Tyndall to law enforcement or
to MBC at the time they became aware of the misconduct. This scandal, combined with
2016 revelations of similar issues occurring at Michigan State University and USA
Gymnastics with respect to sports physician, Larry Nassar, gave rise to the hearing.
Attorney Lowell Brown of Arent Fox LLP (MBC expert), MBC Executive Director
Kirchmeyer, MBC Staff Counsel Kerrie Webb, Supervising Deputy Attorney General Jane
Zack Simon, and T. Scott Vivona from the California Department of Public Health all
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testified before the oversight hearing, discussing the statutory reporting requirements and
common issues or loopholes they have come across in their work.
This hearing likely prompted the legislature to pass SB 1448 (Hill) (Chapter 570,
Statutes of 2018), which requires doctors on probation for specified offenses, including
sexual misconduct, to affirmatively disclose their probationary status to their patients. [See
LEGISLATION]

Cannabis for Medical Purposes
At its April 2018 meeting, MBC discussed proposed revisions to its Guidelines for
Recommending Cannabis for Medical Purposes (“Guidelines”). The Guidelines were
developed, following California’s legalization of cannabis as a permissible treatment
modality, to assure physicians who choose to recommend cannabis for medical purposes
to their patients that they will not be subject to investigation or discipline provided they are
recommending in accordance with accepted standards of medical responsibility. The
revised Guidelines cover a myriad of medical cannabis-related issues, including the
physician-patient relationship (as discussed in Business and Professions Code section
2525.2 and Health and Safety Code section 11362.7(a)); patient evaluation (as discussed
in Business and Professions Code section 2525.3); informed and shared decision making;
treatment agreements (or “treatment plans”); qualifying conditions; ongoing monitoring
and adapting of the treatment plan; consultation and referral; and medical record
maintenance (pursuant to Business and Professions Code section 2266); and physician
conflicts of interest (as discussed in Business and Professions Code sections 2525, 650.01,
and 2525.4).
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MBC originally adopted the Guidelines at MBC’s October 2017 meeting [23:2
CRLR 58]. Additionally, at its April 2018 meeting, MBC member Kristina Lawson gave
an overview of the proposed revisions, mostly minor and technical in nature, to the
Guidelines. The Board voted to approve the revised Guidelines, and directed staff to post
them on the Board’s website and notify physicians about the revised Guidelines.
After the vote, Board President, Dr. GnanaDev announced that MBC’s Marijuana
Task Force would disband because MBC approved the revised Guidelines, so no further
action was needed.

Detection of Overprescribing Physicians:
CURES 2.0
On October 2, 2018, the statutory mandate became effective, requiring prescribers
to consult the Controlled Substance Utilized Review and Evaluation System (CURES 2.0)
before issuing a prescription for Schedule II, III, or IV controlled substances to a patient
for the first time (and at least once every four months thereafter if the substance remains
part of the patient’s treatment plan). The Department of Justice (DOJ) certified CURES
ready to use on a statewide basis in April of 2018, triggering the six month window before
mandatory compliance pursuant to SB 482 (Lara) (Chapter 708, Statutes of 2016).
Pursuant to section 11165.4(d) of the Health and Safety code, MBC is authorized
to impose administrative sanctions on physicians who fail to consult CURES. [23:2
CRLR 53]
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MBC Releases App to Track Physician Discipline
At the Board’s July 2018 meeting, Executive Director Kirchmeyer gave a brief
overview of MBC’s newly developed, self-titled iOS application, which the Board released
in the summer of 2018. The application, which is free, allows users to “follow” up to
sixteen physician licenses, and receive automated license alert notifications if the physician
has his or her license suspended, revoked, or placed on probation, or is subject to
administrative actions. App users will also be notified when one of their selected
physician’s name, address, practice statute, license expiration or survey data change. The
application is available to use 24/7, and MBC released a flyer introducing the application
when it was released. Ms. Kirchmeyer reported that once the iOS version of the application
is working well, the Board will redevelop the application to also work on Android devices.
At the meeting, several consumer advocate provided public comment noting that
while the application improves consumer protection it should not be a replacement for
affirmative physician disclosure of probationary status to patients. [See LEGISLATION]

Proposed Changes to Regulations Regarding
Notice to Patients and Clients
At its July meeting, MBC staff counsel presented proposed amendments and
additions to the Board’s regulations pertaining to patient notification about the Board for
the Board’s discussion and approval. SB 798 (Hill) (Chapter 775, Statutes of 2017) added
section 2026 to the Business and Professions Code, which requires the Board to
initiate the process of adopting regulations on or before January 1, 2019, to
require its licentiates and registrants to provide notice to their clients or
patients that the practitioner is licensed or registered in this state by the
board, that the practitioner’s license can be checked, and that complaints
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against the practitioner can be made through the board’s Internet Web site
or by contacting the board.
Specifically, staff proposed amending sections 1355.4 and 1379.58, Title 16 of the
CCR to conform to the statutory language, including that the notification be made in the
patient’s primary language, and adding sections 1378.5 and 1379.4 to impose similar notice
requirements on research psychoanalysts and licensed midwives, respectively.
Multiple MBC members and a representative from the California Medical
Association voiced concerns regarding the language accessibility of the Board’s materials
under the proposed requirements. Ms. Webb then explained that various proposals and
suggestions to make the Board’s notice materials downloadable in multiple languages is
within the Board’s authority. After discussion, the Board unanimously voted to approve
and submit the proposed regulations to DCA for review.

Mexico Pilot Program Orientation Program
At its July 2018 meeting, April Alameda, Chief of Licensing for MBC, discussed
the “Mexico Pilot Program” in length. Ms. Alameda explained that the program, first
approved by legislation in 2003, was intended to allow up to 30 Mexico-licensed
physicians specializing in a variety of practice areas to practice in medically underserved
parts of California for a period of three years. Each physician selected under the program
is required to complete an MBC-approved, six-month orientation program on the
California health care delivery system before coming to California. However, the Board
never received proper funding to support and implement the program.
The Board is required to approve of the pilot program’s orientation program before
selected individuals take the course. Board staff conducted an initial review of the course
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curriculum before turning it over to a Board Licensing Medical Consultant, Dr. Mark
Servis. Dr. Servis conducted a thorough review of the orientation program and its
curriculum and had several critiques of the program which he sent back to the pilot
program. The pilot program incorporated the necessary changes and Dr. Servis received
back a “comprehensively modified curriculum with significant modifications.”
Dr. Maximiliano Cuevas, Chief Executive Officer of the Clinica de Salud in
Salinas, discussed his support of the pilot program, its intended goals, and the potential
benefits it may produce. Arnoldo Torres, a private policy consultant and author of the
above-referenced legislation that greenlit the pilot program, noted the difficulties in getting
the program implemented and clarified the eligibility requirements for the program.
Finally, Dr. Hannah Rhee voiced her support for including diversity and language training
as part of the orientation program and training process. The Board voted to approve the
Mexico Pilot Program.

LEGISLATION
SB 1448 (Hill), as amended August 23, 2018, adds sections 2228.1 and 2228.5 to
the Business and Professions Code. Section 2228.1 requires certain MBC licensees to
affirmatively disclose their (1) probation status, (2) the length of the probationary period,
(3) the end date of the probationary period, (4) any and all practice restrictions placed on
the licensee by MBC, (5) MBC’s telephone number, and (6) an explanation of how the
patient can access the licensee’s profile page on MBC’s website to get further information
about the licensee’s probation. MBC licensees on probation will have to affirmatively
disclose the above information to a patient (or to the patient’s guardian or health care
surrogate) before the patient’s first appointment following the probationary order. The
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bill’s affirmative disclosure provisions are triggered when—as established by an MBC
administrative hearing, admission by licensee, or prima facie showing in a settlement
agreement—a licensee has: (1) committed sexual abuse or misconduct with a patient; (2)
abused drugs or alcohol resulting in patient harm or impairment of the licensee’s ability to
safely practice medicine; (3) been criminally convicted for a crime which directly involved
harm to a patient; or (4) abused medication prescribing privileges resulting in patient harm
and a probationary period of at least five years. Section 2228.5 further provides that
patients must sign a copy of the disclosure notice required by the section and that the
patient-signed disclosure notice is inapplicable if (1) the patient (or the patient’s guardian
or health care surrogate) was unable to understand the disclosure notice, (2) the patient’s
visit is due to a time-sensitive medical emergency, (3) the licensee serving as the treating
physician is not known to the patient prior to the patient’s visit, or (4) the licensee is not
directly treating the patient. Finally, the section requires MBC to post information related
to licensee probation in plain sight on the licensee’s profile page on the MBC website.
[23:2 CRLR 54]
Sections 2228.1 and 2228.5 become effective on July 1, 2019. Governor Jerry
Brown signed SB 1448 on September 19, 2018 (Chapter 570, Statutes of 2018).
AB 2487 (McCarty), as amended August 8, 2018, adds section 2190.6 to the
Business and Professions Code. Existing section 2190.5 requires physicians and surgeons
to complete twelve credit hours of continuing medical education (CME) in the subjects of
pain management and the treatment of terminally ill and dying patients. New section
2190.6 provides that as an alternative to the CME requirement in 2190.5, licensed
physicians and surgeons may complete a one-time CME course of twelve credit hours in
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the subjects of treatment and management of opiate-dependent patients, including eight
hours of buprenorphine (or related) treatment for opioid-dependent patients. If a licensed
physician or surgeon meets the requirements of a “qualifying physician” as defined by the
Comprehensive Addiction Recovery Act of 2016 (CARA), the licensee is exempt from the
above provision in section 2190.6. Licensed physicians and surgeons who choose to
comply with section 2190.6 as an alternative to complying with section 2190.5 (as allowed
by this section) are required to satisfy the provisions of the section 2910.6 by his or her
next upcoming license renewal date. Finally, section 2910.6 stipulates that MBC shall
determine whether a licensed physician or surgeon has met the section’s requirements.
Governor Jerry Brown signed AB 2487 on September 7, 2018 (Chapter 301,
Statutes of 2018).
SB 1109 (Bates), as amended August 24, 2018, amends sections 2190.5, 2191, and
2196.2 of the Business and Professions Code to adjust existing mandatory CME course
content, on pain management and treating terminally ill patients, for physician and
surgeons licensed on or after January 1, 2019, to include materials covering the risks
associated with the use of Schedule II drugs. Amended section 2191 specifically directs
MBC to give “highest priority” to developing a CME course on pain management and the
risk of addiction associated with the use of Schedule II drugs. Finally, amended section
2196.2 requires MBC to develop and distribute educational and informational materials
regarding pain management techniques and the risk of addiction associated with the use of
Schedule II drugs to all licensed physicians, surgeons, and general acute care hospitals in
California.
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Governor Jerry Brown signed SB 1109 on September 22, 2018 (Chapter 693,
Statutes of 2018).
AB 2760 (Wood), as amended August 15, 2018, adds Article 10.7 (commencing
with section 740) to the Business and Professions Code to require prescribers to offer
prescriptions for naloxone hydrochloride or another federally-approved drug approved for
the partial or complete reversal of opioid depression (a life-threatening slowing of the
central nervous and respiratory systems that occurs after an opioid overdose) to a patient
when certain specified conditions are present. Article 10.7 also requires prescribers to
provide educational and informational materials for their patients on overdose prevention
and the use of naloxone hydrochloride or other similarly-purposed and federally-approved
drugs.
Governor Jerry Brown signed AB 2760 on September 10, 2018 (Chapter 324,
Statutes of 2018).
AB 2783 (O’Donnell), as amended August 22, 2018, amends sections 11055 and
11056 of the Health and Safety Code to reclassify certain specified hydrocodone
combination products as Schedule II controlled substances. Re-classifying specified
hydrocodone combination products as Schedule II controlled substances imposes more
stringent requirements on the prescribing of hydrocodone combination products, including
a limitation on refills.
Governor Jerry Brown signed AB 2783 on September 20, 2018 (Chapter 589,
Statutes of 2018).
AB 1751 (Low), as amended August 24, 2018, amends section 11165 of the Health
and Safety Code to authorize the California Department of Justice (DOJ) to share
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prescription records directly with the state’s drug monitoring programs (PDMP), the
Controlled Substance Utilization Review and Evaluation System (CURES), and databases
across state lines without having to go through a data share hub provided California patient
privacy and data security regulations and standards are met and observed. Section 11164
also requires the DOJ to, no later than July 1, 2020, adopt regulations related to accessing
and using the information stored in CURES. MBC previously voted unanimously to
support AB 1751 [23:2 CRLR 57] and did so again at its July 2018 meeting on the condition
that the bill is amended to remove the ability of health plans and insurers to access CURES.
Governor Jerry Brown signed AB 1751 on September 18, 2018 (Chapter 478,
Statutes of 2018).
AB 1753 (Low), as amended August 24, 2018, amends sections 11161.5, 11162.1,
and 11165 of the Health and Safety Code to allow the DOJ to, by January 1, 2020, limit or
reduce the number of approved security printers for controlled substance prescription pads
to three. [23:2 CRLR 58] Additionally, the amended sections require controlled substance
prescription forms to have individualized, unique serial numbers and require each printer
to submit certain information to the DOJ for each dispensed prescription form. The
purported purpose of requiring each prescription pad to be serialized and linked to CURES
is to help law enforcement better identify the circulation of fake prescriptions written using
lost or stolen prescription pads. [23:2 CRLR 58] Dispensing pharmacies, clinics, and other
dispensers are also required to include each prescription form’s serial number in applicable
reports submitted to the DOJ.
Governor Jerry Brown signed AB 1753 on September 18, 2018 (Chapter 479,
Statutes of 2018).
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AB 2086 (Gallagher), as amended August 14, 2018, adds section 11165.6 to the
Health and Safety Code to allow prescribers to access CURES for a list of patients for
whom that prescriber is listed as a prescriber in CURES.
Governor Jerry Brown signed AB 2086 on September 6, 2018 (Chapter 274,
Statutes of 2018).
AB 1996 (Lackey), as amended August 14, 2018, would have amended Business
and Professions Code section 2525.1 to require MBC to consult with the California
Cannabis Research Program regarding the development and adoption of medical guidelines
for the appropriate administration and use of medicinal cannabis. AB 1996 passed floor
votes in both the Assembly and the Senate but was vetoed by Governor Jerry Brown on
September 20, 2018. In his veto message, Governor Brown stated that
I am returning Assembly Bill 1996 without my signature.
This bill renames the California Marijuana Research Program as the
California Cannabis Research Program and expands the areas of research
that can be undertaken. The bill also prohibits the money appropriated to
the Cannabis Research Program from the Cannabis Tax Fund to pay for the
provisions of this bill.
This bill contains provisions that directly conflict with the Control,
Regulate, and Tax Adult Use of Marijuana Act, which the voters approved
in November 2016. For this reason, I cannot support this measure.
AB 710 (Wood), as amended April 2, 2018, adds section 26002 to the Business and
Professions Code and section 11150.2 to the Health and Safety Code to allow a physician,
pharmacist, or other authorized healing arts licensee acting within their scope of practice
to prescribe, furnish, or dispense cannabidiol (CBD) if cannabidiol is excluded from
Schedule I classification under the federal Controlled Substances Act and placed on a
schedule other than Schedule I or if the United States Food and Drug Administration
approves a cannabidiol product. [23:2 CRLR 59]
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AB 710 was an urgency statute, and as such took effect as soon as the governor
signed it. Governor Jerry Brown signed AB 710 on July 9, 2018 (Chapter 62, Statutes of
2018).
AB 1791 (Waldron), as amended April 2, 2018, adds section 2191.4 to the
Business and Professions Code to require MBC to consider including a continuing
education course integrating HIV/AIDS pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) medication maintenance and counseling in primary care
settings. MBC had previously been directed by its staff to take a neutral position on AB
1791; historically, MBC has opposed bills requiring physicians to take certain CME
courses. [23:2 CRLR 60]
Governor Jerry Brown signed AB 1791 on July 18, 2018 (Chapter 122, Statutes of
2018).
AB 2311 (Arambula), as introduced February 13, 2018, amends section 2066.5 of
the Business and Professions Code to permanently authorize a clinical instruction program
for some certain international medical graduates (IMGs) at the University of California at
Los Angeles’ David Geffen School of Medicine as part of the School of Medicine’s
existing pre-residency training program. Each participating IMG must graduate from an
MBC-recognized medical school at the time of their selection for the program. AB 2311
also eliminates a sunset provision in the Business and Professions Code that would have
ended the program on January 1, 2019. As such, the operation of the provisions in section
2066.5 is set to continue indefinitely.
Governor Jerry Brown signed AB 2311 on July 20, 2018 (Chapter 144, Statutes of
2018).
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AB 505 (Caballero), as amended June 28, 2018, amends section 2334 of the
Business and Professions Code to authorize an administrative law judge to extend the time
period for the exchange of information regarding the use of expert testimony in matters
brought by MBC, upon a motion based on a showing of good cause, for a period not to
exceed 100 calendar days.
Governor Jerry Brown signed AB 505 on September 18, 2018 (Chapter 469,
Statutes of 2018).
AB 2461 (Flora), as amended May 25, 2018, amends section 11105.2 of the Penal
Code to require the DOJ to provide notice and updates to MBC regarding arrests or
dispositions involving a licensee. The amended section also requires DOJ provide notice
to the State Department of Social Services and to the Osteopathic Medical Board.
Governor Jerry Brown signed AB 2461 on September 7, 2018 (Chapter 300,
Statutes of 2018).
AB 2789 (Wood), as amended August 14, 2018, adds section 688 to the Business
and Professions Code to require health care practitioners authorized to prescribe to have
the capability to transmit electronic data transmission prescriptions. Section 688 requires
pharmacies to have capability to receive data transmission prescriptions. Under section
688, beginning January 1, 2022, health care practitioners, currently authorized to prescribe
using oral, written, or electronic transmission, are required to prescribe exclusively using
electronic data transmission prescriptions unless: 1) the prescription is for a Class II
controlled substance; 2) electronic data transmission is not available due to a temporary
technological or electrical failure; 3) the prescriber is issuing a prescription which will be
filled by a pharmacy located outside California; or 4) the prescription is issued in a hospital
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emergency department and one or more of the following conditions are present: (a) patient
lives outside of California, (b) patient lives outside the geographic area of the treating
hospital, (c) patient is homeless or indigent and does not have a preferred pharmacy, or (d)
prescription is issued at a time when the patient’s regular or preferred pharmacy is likely
to be closed.
A pharmacy must immediately notify the prescriber if an electronic data
transmission prescription is not appropriately received or transfer or forward the
prescription to another pharmacy at the request of the patient. Health care practitioners,
pharmacists, or pharmacies that provide health care services to certain individuals under
the jurisdiction of the California Department of Corrections and Rehabilitation are exempt
from the above provisions of section 688. MBC had mixed reactions to AB 2789, with
some members arguing that mandating electronic prescriptions will help eliminate
prescription fraud while other members were concerned with physician access to
appropriate technology. [23:2 CRLR 64]
Governor Jerry Brown signed AB 2789 on September 17, 2018 (Chapter 438,
Statutes of 2018).
AB 2968 (Levine), as amended August 14, 2018, amends sections 337 and 728 of
the Business and Professions Code to transfer the responsibility to prepare, develop, and
disseminate an informational brochure for victims of psychotherapist-client sexual contact
and their advocates to MBC and other related regulatory boards from DCA which is
currently responsible for developing the brochure in conjunction with the office of
Criminal Justice Planning and the office of the Attorney General. The brochure must be
provided to each individual contacting said boards regarding psychotherapist-sexual
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contact and behavior. AB 2986 also revises some of the brochure’s content by expanding
the list of mental health practitioners included in the “psychotherapist” definition, and
requires the brochure be made available on the website of MBC and the website of the
other regulatory boards covered by the bill. [23:2 CRLR 64-65]
Governor Jerry Brown signed AB 2968 on September 26, 2018 (Chapter 778,
Statutes of 2018).
SB 1163 (Galgiani), as amended August 24, 2018, amends section 27521 of the
Government Code to require postmortem examinations and autopsies performed on
unidentified human remains to be completed by a board-certified forensic pathologist,
rather than a coroner. Section 27521 also requires agencies tasked with exhumations to
consult with a board-certified forensic pathologist when performing exhumations.
Governor Jerry Brown signed SB 1163 on September 29, 2018 (Chapter 936,
Statutes of 2018).
SB 1495 (Committee on Health), as amended June 14, 2018, makes
noncontroversial changes to numerous sections of the Business and Professions Code, the
Health and Safety Code, and the Welfare and Institutions Code. Importantly, SB 1495
clarifies language in SB 512 (Hernandez) (Chapter 428, Statutes of 2017) related to patient
notification requirements during the course of non-FDA approved stem cell therapy. [23:2
CRLR 66-67] The bill specifies that stem cell therapies meeting the criteria of sections
1271.10 and 1271.15, Title 21 of the Code of Federal Regulations (i.e., FDA-regulated
stem cell therapies that do not require FDA premarket review or clearance or stem cell
therapies that qualify for an exception) do not fall under the purview of the bill’s notice
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requirements. [23:2 CRLR 66-67] SB 1495 also adds section 1751.5 to the Health and
Safety Code to prescribe the procedures for hospice licensure.
Governor Jerry Brown signed SB 1495 on September 14, 2018 (Chapter 424,
Statutes of 2018).
AB 2138 (Chiu and Low), as amended August 24, 2018, amends sections 7.5, 480,
481, 482, 488, 493 and 11345.2 and adds section 480.2 to the Business and Professions
Code. AB 2138 limits the circumstances under which state regulatory boards under the
DCA may deny professional licensure to individuals who have previously been convicted
of certain specified crimes in the 7 years preceding the date of application and requires
DCA boards to develop criteria for determining whether a crime is directly and adversely
related to the qualifications, functions, or duties of the business or profession a board
regulates; develop procedures when requesting or taking disciplinary action based on an
applicant’s criminal history; and requires boards to annually report specified de-identified
information relating to Board action pertaining to applicants with criminal convictions,
including the number of licensees who were affected, whether they provided evidence of
rehabilitation or mitigation; whether they appealed; the final disposition; and the
voluntarily provided information on the race or gender of any applicant. [23:2 CRLR 67]
AB 2138’s provisions become operative on July 1, 2020. Governor Jerry Brown
signed AB 2138 on September 30, 2018 (Chapter 995, Statutes of 2018).
AB 2193 (Maienschein), as amended August 17, 2018, adds section 1367.625 and
Article 6 (commencing with section 123640) to the Health and Safety Code and adds
section 10123.867 to the Insurance Code to require, by July 1, 2019, licensed health care
practitioners who provide prenatal or postpartum care for mothers to offer screens for
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maternal mental health conditions. Health care service plans and health insurers must
develop maternal mental health programs consistent with sound and accepted clinical
principles and processes by July 1, 2019. Neither section 1367.625 nor section 10123.867
apply to certain specialized health insurers.
Governor Jerry Brown signed AB 2193 on September 26, 2018 (Chapter 755,
Statutes of 2018).
AB 1790 (Salas and Fong), as amended August 23, 2018, adds Part 7.7
(commencing with section 122475) to and repeals section 122477 from the Health and
Safety Code. AB 1790 establishes the Valley Fever Education, Early Diagnosis, and
Treatment Act to require the California Department of Public Health to conduct a valley
fever awareness campaign to communicate the dangers of valley fever to local health
jurisdictions, providers, and the public. AB 1790 also allows the Department of Public
Health to award grants or enter into contracts to perform activities related to the awareness
campaign. AB 1790 contains a sunset provision that makes the above provisions
inoperative on January 1, 2021.
Governor Jerry Brown signed AB 1790 on September 11, 2018 (Chapter 338,
Statutes of 2018).
AB 1659 (Low), as amended January 3, 2018, amends sections 701, 702, and 703
of the Business and Professions Code to prohibit holders of inactive licenses from
representing that they have active licenses. Section 703 also authorizes MBC and other
applicable DCA boards to charge lower inactive license renewal fees.
Governor Jerry Brown signed AB 1659 on September 5, 2018 (Chapter 249,
Statutes of 2018).
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SB 1480 (Hill), as amended August 24, 2018, amends over a dozen sections, and
adds numerous sections to the Business and Professions Code; and amends numerous
sections of the Health and Safety Code. SB 1480 requires all DCA boards to meet at least
two times a year and requires the Director of DCA to amend existing complaint
prioritization guidelines to include the category of “allegations of serious harm to a minor.”
SB 1480 also makes changes to postgraduate license exemptions and to
postgraduate training programs, all of which become operative on January 1, 2020. At the
July 2018 meeting, the Licensing Committee presented an update on the changes to
postgraduate training. The 12-month and 27-month limitations on license exemptions for
medical school graduates enrolled in first-year postgraduate training programs and
residencies and fellowships are deleted. There are changes to the duration of some
postgraduate training programs and licensure procedures upon completion of those
programs. Directors of California-based postgraduate training programs must report to
MBC and provide documents regarding a postgraduate trainee’s status in the program
within 30 days of certain events such as resignation or termination or in the event the
program is extended.
Section 2428 is amended to increase the length (from two years to three years) of
approved postgraduate training an applicant must complete if they are applying for a new
license after a period of five years of non-renewal after they voluntarily cancelled or failed
to renew their license. The bill further makes adjustments to the exam and application fee
structure, including requiring applicants to pay nonrefundable application and processing
fees. The remainder of the bill does not affect MBC.
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Governor Jerry Brown signed SB 1480 on September 19, 2018 (Chapter 571,
Statutes of 2018).

Legislative Bills that Died
The following bills reported in Volume 23, No. 2 (Spring 2018) died in committee
or otherwise failed to be enacted during 2018: AB 2741 (Burke), which would have
prohibited prescribers from prescribing more than a five-day supply of opioid medication
to a minor except for specified medical uses; AB 1998 (Rodriguez), which would have
required prescribers of Schedule II and Schedule III opioids to adopt and regularly update
a safe opioid prescribing policy; AB 182 (Waldron), relating to the Heroin Opioid
Education Program; AB 1752 (Low), which would have reduced the timeframe in which
dispensers must report certain information to CURES from seven days to one day; AB
1002 (Cooley), which would have required MBC to consult with the California Cannabis
Research Program to promulgate guidelines regarding medical cannabis; AB 1795
(Gipson), relating to emergency medical services agencies creating transport plans for
certain triaged patients directly to a behavioral health facility or sobering center rather than
an acute care facility; AB 2539 (Mathis), relating to definitional changes and the
requirements of the Steven M. Thompson Physician Corps Loan Repayment Program; AB
2904 (Carrillo), which would have required health care providers to document patient
consent to the use of telehealth; AB 2483 (Voepel), which would have required public
entities, including MBC, to pay trebled antitrust awards against regulatory board members
for acts or omissions within the scope of a member’s official capacity as a member of the
regulatory board; AB 2682 (Burke), which would have expanded the authority of certified
nurse-midwives to allow them to practice and prescribe in a variety of settings without
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physician supervision; AB 2943 (Low), which would have reclassified the selling of
services related to changing the sexual orientation of individuals as an unlawful practice
under the Consumer Legal Remedies Act; AB 1368 (Calderon), relating to provider
authority to sign patient forms relating to Medi-Cal benefits and services; AB 18 (Garcia),
which would have removed a requirement that physician orientation for the Mexico Pilot
Program be six months in length; SB 944 (Hertzberg), relating to the development of
community paramedicine programs under the California Emergency Medical Services
Authority; SB 1238 (Roth), relating to patient rights to access medical records; and SB
1336 (Morrell), relating to the scope of information included on the annual End of Life
Option Act Report.

LITIGATION
♦ Selvidge v. Tang. On May 16, 2018, the Supreme Court of California denied the
defendant’s petition for review and request for depublication in Selvidge v. Tang, Case No.
S248211, 2018 Cal. LEXIS 3548 (May 18, 2018). Defendant petitioned the Supreme Court
of California for review and requested depublication after the decision in Selvidge v. Tang,
20 Cal. App. 5th 1279 (2018). [23:2 CRLR 70-72]

RECENT MEETINGS
At its April 2018 meeting, MBC voted to appoint Dr. Hawkins to serve as the
Board’s representative on the Health Professions Education Foundation (HPEF). The
Board also unanimously voted to change the term limits for HPEF appointees to four years,
or until the MBC member’s term on the Board expires, whichever comes first.
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At its July 2018 meeting, the Board elected public member Denise Pines to serve
as MBC president, and licensee member, Dr. Lewis, to serve as Vice President, and
licensee member Dr. Bholat as Secretary.
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